ncRNA | Transmission by small extracellular vesicles | Target | Downstream signaling/molecular mechanism | Effect in recipient cells | Ref | |
---|---|---|---|---|---|---|
from… | to… | |||||
microRNAs | ||||||
21-5p | TAM | PDAC | KLF3 | Â | Stemness, invasion, migration | [83] |
 | PSCs | PDAC |  | Induction of Ras/ERK/Akt | Proliferation, migration | [106] |
27a | PDAC | Endothelial cells | BTG2 | Â | Angiogenesis, tumor growth | [114] |
106b | PSCs | PDAC | TP53INP1 | Â | GEM resistance | [99] |
125b-5p | Highly malignant PDAC | Less malignant PDAC | STARD13 | Induction of MEK2/ERK2 | Invasion, migration, EMT | [48] |
143 | hMSCs | PDAC | lncRNA-RP11-363N22.3 | Â | Promotes apoptosis, inhibits proliferation, invasion, migration | [102] |
145 | Primary tumor stroma | PDAC | Â | Â | Apoptosis | [101] |
146a | GEM-treated CAFs | PDAC | Â | Induction of Snail | GEM resistance | [100] |
155 | Pancreatic fibroblasts | CAFs | TP53INP1 | Â | Conversion of PSCs into CAFs | [98] |
 | TAM | Endothelial cells | E2F2 |  | Angiogenesis, tumor growth | [113] |
 | GEM-resistant PDAC | PDAC | TP53INP1 |  | GEM resistance | [127] |
 | GEM-treated PDAC | PDAC | DCK |  | GEM resistance | [126] |
203 | PDAC | Dendritic cells | TLR4 | Inhibition of TNF-α/IL-12 expression | Immunosuppression | [72] |
210 | GEM-treated CSCs | regular PDAC | Â | Induction of mTOR | Stemness, GEM resistance | [131] |
212-3p | PDAC | Dendritic cells | RFXAP | Inhibition of MHC II expression | Immunosuppression | [72] |
221-5p | TAM | Endothelial cells | E2F2 | Â | Angiogenesis, tumor growth | [113] |
222 | Highly malignant PDAC | Less malignant PDAC | PPP2R2A | Induction of AKT, inhibition of p27 import to the nucleus | Proliferation, invasion, migration | [49] |
301a-3p | Hypoxic PDAC | Macrophages | PTEN | Induction of PI3K/AKT/mTOR | M1-to-M2 polarization of macrophages, immunosuppression | [84] |
365 | TAM | PDAC | BTG2 | Induction of FAK/AKT | Proliferation, invasion, migration | [78] |
 |  |  |  | Increase of intracellular NTPs and CDA | GEM resistance | [77] |
494 | PDAC | LN stroma cells, lung fibroblasts | CDH17 | Â | Promotes pre-metastatic niche | [58] |
 |  | PBMCs |  | Increase of intracellular calcium fluxes | Expansion of MDSCs and immunosuppression | [74] |
501-3p | TAM | PDAC | Â | Induction of TGFBR3 | Anti-apoptosis, proliferation, stemness, invasion, migration | [82] |
 |  | Endothelial cells |  |  | Angiogenesis |  |
542-3p | PDAC | LN stroma cells, lung fibroblasts | CDH17 | Â | Promotes pre-metastatic niche | [58] |
616-3p | hypoxic PSCs | PDAC | PTEN | Induction of AKT | Proliferation, invasion, migration | [107] |
1260a | PDAC | PBMC | Â | Increase of intracellular calcium fluxes | Expansion of MDSCs and immunosuppression | [74] |
1290 | PDAC | PSCs | Â | Induction of ERK/Akt | Conversion of PSCs into profibrotic CAFs | [97] |
3607-3p | natural killer cells | PDAC | IL-26 | Â | Inhibits proliferation, invasion, migration | [76] |
4465 | hypoxic PSCs | PDAC | PTEN | Induction of AKT | Proliferation, invasion, migration | [107] |
5703 | PSCs | PDAC | CMTM4 | Induction of PAK4/PI3K/Akt | Proliferation | [108] |
Long non-coding RNAs | ||||||
CCAT1 | PDAC | Endothelial cells | miR-138-5p | Induction of HMGA1 | Angiogenesis, tumor growth | [115] |
HULC | PDAC | PDAC | Â | Â | EMT, invasion, migration | [56] |
SBF2-AS1 | TAM | PDAC | miR-122-5p | Induction of XIAP | Proliferation, invasion, migration | [79] |
Sox2ot | Highly malignant PDAC | Less malignant PDAC | miR-200 family | Induction of Sox2 | Stemness, EMT, metastasis | [53] |
UCA1 | Hypoxic PDAC | Endothelial cells | miR-96-5p | Induction of AMOTL2/ERK1/2 | Angiogenesis, tumor growth | [116] |
Circular RNAs | ||||||
0000069 | PDAC | Benign pancreas | Â | Induction of STIL | Cell cycle progression, proliferation, migration | [59] |
0030167 | BM-MSCs | PDAC | miR-338-5p | Induction of Wif1, inhibition of Wnt8/β-catenin | Inhibits proliferation, invasion, migration, stemness | [103] |
IARS | PDAC | Endothelial cells | miR-122 | Â | Endothelial permeability, metastasis | [57] |
PDE8A | Highly malignant PDAC | Less malignant PDAC | miR-338 | Induction of MACC1/MET/ERK/AKT | Proliferation, invasion, metastasis | [47] |
ZNF91 | Hypoxic PDAC | Normoxic PDAC | miR-23b-3p | Induction of SIRT1 and glycolysis | GEM resistance | [133] |